Overview
Age-related Macular Degeneration Plasma | High-Quality Human Plasma from Age-related Macular Degeneration (AMD) Donors
Age-related Macular Degeneration Plasma is collected from donors clinically diagnosed with age-related macular degeneration (AMD) and processed within hours of collection to preserve key analytes such as cytokines, proteins, and metabolites. This human AMD plasma supports research focused on inflammatory pathways, immune profiling, and biomarker discovery in AMD pathophysiology.
Product Features
- Research Use Only (RUO)
- Collected from donors clinically confirmed Age-related Macular Degeneration (AMD)
- Processed within one day of collection
- IRB-approved protocols and informed consent
- Custom aliquot volumes available upon request
Donor Metadata
- Verified AMD diagnosis
- Demographic data: age, sex assigned at birth, race/ethnicity
- Donor-reported medications, allergies, and comorbidities
- Additional AMD-specific metadata available including ophthalmological findings
Applications
- Biomarker discovery and validation
- Cytokine and inflammation profiling
- Metabolomics and proteomics studies
- Therapeutic response research
Compliance and Quality Assurance
- IRB-approved and HIPAA-compliant protocols
- Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
- Documentation support available for regulatory review
Ordering and Customization
Age-related Macular Degeneration (AMD) plasma is available in a range of standard and custom volumes. For international orders or documentation requirements, please email to ensure compatibility with your country’s regulations.
Protocol and Documentation
Resources and Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.